EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 195 filers reported holding EDITAS MEDICINE INC in Q4 2018. The put-call ratio across all filers is 2.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,397,760 | -4.2% | 179,200 | +1.1% | 0.00% | 0.0% |
| Q2 2023 | $1,459,179 | +35.6% | 177,300 | +19.5% | 0.00% | 0.0% |
| Q1 2023 | $1,075,900 | -26.9% | 148,400 | -10.6% | 0.00% | 0.0% |
| Q4 2022 | $1,472,420 | -25.6% | 166,000 | +2.7% | 0.00% | 0.0% |
| Q3 2022 | $1,979,000 | +3.5% | 161,700 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,913,000 | -37.8% | 161,700 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $3,076,000 | -22.7% | 161,700 | +7.9% | 0.00% | 0.0% |
| Q4 2021 | $3,977,000 | -35.4% | 149,800 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $6,154,000 | -26.8% | 149,800 | +0.9% | 0.00% | -20.0% |
| Q2 2021 | $8,411,000 | +40.6% | 148,500 | +4.3% | 0.01% | +25.0% |
| Q1 2021 | $5,981,000 | -39.4% | 142,400 | +1.1% | 0.00% | -42.9% |
| Q4 2020 | $9,871,000 | +154.5% | 140,800 | +1.9% | 0.01% | +133.3% |
| Q3 2020 | $3,878,000 | -4.0% | 138,200 | +1.2% | 0.00% | 0.0% |
| Q2 2020 | $4,038,000 | +127.5% | 136,500 | +52.5% | 0.00% | +50.0% |
| Q1 2020 | $1,775,000 | -29.7% | 89,500 | +4.9% | 0.00% | -33.3% |
| Q4 2019 | $2,526,000 | +33.7% | 85,300 | +2.6% | 0.00% | +50.0% |
| Q3 2019 | $1,890,000 | -4.5% | 83,100 | +3.9% | 0.00% | 0.0% |
| Q2 2019 | $1,979,000 | +23.8% | 80,000 | +22.3% | 0.00% | 0.0% |
| Q1 2019 | $1,599,000 | +11.2% | 65,400 | +3.5% | 0.00% | 0.0% |
| Q4 2018 | $1,438,000 | -26.9% | 63,200 | +2.3% | 0.00% | 0.0% |
| Q3 2018 | $1,966,000 | -7.3% | 61,800 | +4.4% | 0.00% | 0.0% |
| Q2 2018 | $2,121,000 | +42.8% | 59,200 | +32.1% | 0.00% | 0.0% |
| Q1 2018 | $1,485,000 | +7.8% | 44,800 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $1,377,000 | +43.0% | 44,800 | +11.7% | 0.00% | 0.0% |
| Q3 2017 | $963,000 | +43.1% | 40,100 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $673,000 | -24.8% | 40,100 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $895,000 | +83.0% | 40,100 | +33.2% | 0.00% | 0.0% |
| Q4 2016 | $489,000 | +267.7% | 30,100 | +204.0% | 0.00% | – |
| Q3 2016 | $133,000 | -45.0% | 9,900 | 0.0% | 0.00% | – |
| Q2 2016 | $242,000 | – | 9,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |